(Q43296450)

English

Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival

scientific article published in September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 November 2017

Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival (English)

1 reference

Europe PubMed Central

18 November 2017

1 reference

based on heuristic

inferred from title

pancreatic adenocarcinoma

1 reference

based on heuristic

inferred from title

author name string

Muhammad Wasif Saif

1

1 reference

Europe PubMed Central

18 November 2017

Sharukh Hashmi

2

1 reference

Europe PubMed Central

18 November 2017

Diana Bell

3

1 reference

Europe PubMed Central

18 November 2017

Robert B Diasio

4

1 reference

Europe PubMed Central

18 November 2017

language of work or name

0 references

publication date

1 September 2009

1 reference

Europe PubMed Central

18 November 2017

Expert Opinion on Drug Safety

1 reference

Europe PubMed Central

18 November 2017

8

1 reference

Europe PubMed Central

18 November 2017

5

1 reference

Europe PubMed Central

18 November 2017

507-514

1 reference

Europe PubMed Central

18 November 2017

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1517%2F14740330903173217

21 January 2018

Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions.

1 reference

https://api.crossref.org/works/10.1517%2F14740330903173217

21 January 2018

Capecitabine: preclinical pharmacology studies

1 reference

https://api.crossref.org/works/10.1517%2F14740330903173217

21 January 2018

Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1517%2F14740330903173217

21 January 2018

Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1517%2F14740330903173217

21 January 2018

Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome

1 reference

https://api.crossref.org/works/10.1517%2F14740330903173217

21 January 2018

Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase

1 reference

https://api.crossref.org/works/10.1517%2F14740330903173217

21 January 2018

Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1517%2F14740330903173217

21 January 2018

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14740330903173217

21 January 2018

Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients

1 reference

https://api.crossref.org/works/10.1517%2F14740330903173217

21 January 2018

Identifiers

10.1517/14740330903173217

1 reference

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43296450&oldid=2138305667"